“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...
Chance AI, the pioneering visual-first AI agent, has officially announced its entry into the Indian market. The launch is led ...
Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).
Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...
Ice cream comes in many different flavors. But even pure ice, which consists only of water molecules, has been discovered to ...
AI agents are now hacking computers. They’re getting better at all phases of cyberattacks, faster than most of us expected. They can chain together different aspects of a cyber operation, and hack ...
Israel and Hamas have agreed upon implementing the first phase of Trump’s 20-point peace plan. However, after the first phase ...
Researchers discovered that stevioside, a compound from the Stevia plant, enhances the skin absorption of minoxidil, the main ...
The Phase 3 trial is scheduled to begin in the first quarter of fiscal year 2026 and conclude within fiscal year 2027. Since this drug has received orphan drug designation from the Ministry of Health, ...
NASA confirmed that nuclear-micropowered probes (NMPs) using tritium betavoltaic power technology is possible. A new study ...
The Bulls N’ Bears ASX Runner of the Week is… Infini Resources after it nailed eye-popping uranium visuals and XRF hits at ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback